| 证券代码 | SNOAW.O |
| 证券名称 | Sonoma Pharmaceuticals Inc Wt |
| 证券类型 | 美国权证 |
| 上市场所 | 纳斯达克交易所 |
| 上市板块 | - |
| 发行方式 | - |
| 首发上市日 | 2015-01-21 |
| 首发价格(元) | - |
| 首发数量(股) | 0 |
| 首发募资额(元) | - |
| 首发主承销商 | - |
| 货币单位 | - |
| 公司名称 | Sonoma Pharmaceuticals, Inc. |
| 注册地址 | 美国特拉华州 |
| 办公地址 | 1129 North McDowell Blvd., Petaluma, California, USA |
| 成立日期 | 2006-12 |
| 董事会主席 | - |
| 公司属地 | United States 美国 |
| 公司网址 | www.sonomapharma.com |
| 电话 | +1 (707) 283-0550 |
| 传真 | +1 (707) 283-0551 |
| 公司简介 | Sonoma Pharmaceuticals, Inc. is a specialty pharmaceutical company dedicated to identifying, developing and commercializing unique, differentiated therapies to millions of patients living with chronic skin conditions. They offer early-intervention relief with virtually no side-effects or contraindications. They believe their products, which are sold throughout the United States and internationally, have improved patient outcomes for more than six million patients by treating and reducing certain skin diseases including acne, atopic dermatitis, scarring, infections, itch, pain and harmful inflammatory responses. Their vision is to be a catalyst for improved care and increased access for all patients. |